Variant report
Variant | nsv564067 |
---|---|
Chromosome Location | chr14:25262373-25262952 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:25257418..25259625-chr14:25262130..25263668,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11627616 | chr14:25262373-25262374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs860540 | chr14:25262397-25262398 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs80316599 | chr14:25262408-25262409 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183015518 | chr14:25262419-25262420 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554646334 | chr14:25262424-25262425 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12587304 | chr14:25262425-25262426 | Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs78666713 | chr14:25262476-25262477 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373366673 | chr14:25262514-25262515 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs147834141 | chr14:25262515-25262516 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188358770 | chr14:25262554-25262555 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536284573 | chr14:25262585-25262586 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs77628746 | chr14:25262612-25262613 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192916107 | chr14:25262629-25262630 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561395607 | chr14:25262656-25262657 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530142136 | chr14:25262667-25262668 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182802904 | chr14:25262674-25262675 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532873042 | chr14:25262694-25262695 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs56369292 | chr14:25262766-25262767 | Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs538682161 | chr14:25262804-25262805 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371262150 | chr14:25262861-25262862 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs60958731 | chr14:25262891-25262892 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574262769 | chr14:25262902-25262903 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538506932 | chr14:25262909-25262910 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs854366 | chr14:25262952-25262953 | Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
severe speech impairment | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Cancer | 21183584 | CNVD |
Leukoplakia | 24403051 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic myeloid leukemia | 16756668 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Multiple myeloma | 16616336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:25259000-25263800 | Weak transcription | Fetal Brain Male | brain |
2 | chr14:25261800-25264400 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
3 | chr14:25261800-25268200 | Weak transcription | Fetal Lung | lung |
4 | chr14:25262400-25263400 | Bivalent Enhancer | HepG2 | liver |